Telstar®

Welcoming over 550 key leaders across 3 cutting-edge programmes, looking at new strategies for optimizing biologic formulations such as antibodies, proteins and vaccines, the latest developments in inhaled vaccines and antibiotics, and the challenges at the forefront of biomanufacturing research; from cell & gene therapy and biologics biomanufacturing through to upstream and downstream bioprocessing